These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 27608412

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neisseria gonorrhoeae uses two lytic transglycosylases to produce cytotoxic peptidoglycan monomers.
    Cloud-Hansen KA, Hackett KT, Garcia DL, Dillard JP.
    J Bacteriol; 2008 Sep; 190(17):5989-94. PubMed ID: 18567658
    [Abstract] [Full Text] [Related]

  • 3. Neisseria gonorrhoeae Lytic Transglycosylases LtgA and LtgD Reduce Host Innate Immune Signaling through TLR2 and NOD2.
    Knilans KJ, Hackett KT, Anderson JE, Weng C, Dillard JP, Duncan JA.
    ACS Infect Dis; 2017 Sep 08; 3(9):624-633. PubMed ID: 28585815
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neisseria gonorrhoeae Crippled Its Peptidoglycan Fragment Permease To Facilitate Toxic Peptidoglycan Monomer Release.
    Chan JM, Dillard JP.
    J Bacteriol; 2016 Nov 01; 198(21):3029-3040. PubMed ID: 27551020
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the role of LtgB, a putative lytic transglycosylase in Neisseria gonorrhoeae.
    Kohler PL, Cloud KA, Hackett KT, Beck ET, Dillard JP.
    Microbiology (Reading); 2005 Sep 01; 151(Pt 9):3081-3088. PubMed ID: 16151218
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. AtlA functions as a peptidoglycan lytic transglycosylase in the Neisseria gonorrhoeae type IV secretion system.
    Kohler PL, Hamilton HL, Cloud-Hansen K, Dillard JP.
    J Bacteriol; 2007 Aug 01; 189(15):5421-8. PubMed ID: 17526702
    [Abstract] [Full Text] [Related]

  • 9. Defective lytic transglycosylase disrupts cell morphogenesis by hindering cell wall de-O-acetylation in Neisseria meningitidis.
    Williams AH, Wheeler R, Deghmane AE, Santecchia I, Schaub RE, Hicham S, Moya Nilges M, Malosse C, Chamot-Rooke J, Haouz A, Dillard JP, Robins WP, Taha MK, Gomperts Boneca I.
    Elife; 2020 Feb 05; 9():. PubMed ID: 32022687
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Peptidoglycan fragment release and NOD activation by commensal Neisseria species from humans and other animals.
    Harris-Jones TN, Chan JM, Hackett KT, Weyand NJ, Schaub RE, Dillard JP.
    Infect Immun; 2024 May 07; 92(5):e0000424. PubMed ID: 38563734
    [Abstract] [Full Text] [Related]

  • 17. Neisseria gonorrhoeae PBP3 and PBP4 Facilitate NOD1 Agonist Peptidoglycan Fragment Release and Survival in Stationary Phase.
    Schaub RE, Perez-Medina KM, Hackett KT, Garcia DL, Dillard JP.
    Infect Immun; 2019 Feb 07; 87(2):. PubMed ID: 30510100
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Pathogenic Neisseria Use a Streamlined Set of Peptidoglycan Degradation Proteins for Peptidoglycan Remodeling, Recycling, and Toxic Fragment Release.
    Schaub RE, Dillard JP.
    Front Microbiol; 2019 Feb 07; 10():73. PubMed ID: 30766523
    [Abstract] [Full Text] [Related]

  • 20. Mutation of mltG increases peptidoglycan fragment release, cell size, and antibiotic susceptibility in Neisseria gonorrhoeae.
    Harris-Jones TN, Pérez Medina KM, Hackett KT, Schave MA, Klimowicz AK, Schaub RE, Dillard JP.
    J Bacteriol; 2023 Dec 19; 205(12):e0027723. PubMed ID: 38038461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.